Literature DB >> 3016096

Preparation of Fab fragments from a mouse monoclonal IgM.

J M Bidlack, P C Mabie.   

Abstract

A procedure is described for preparing and purifying Fab fragments from a mouse monoclonal IgM. The IgM was digested with trypsin in the presence of the reducing agent, cysteine. The resulting Fab fragments were alkylated with iodoacetamide and purified using a Sephacryl S-200 column. The Fab fragments had a molecular weight of 48 000 as determined by SDS polyacrylamide gel electrophoresis and molecular sieve chromatography. This procedure has been successfully used with five different mouse monoclonal IgM. The Fab fragments bound antigen with the same specificity as the whole IgM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016096     DOI: 10.1016/0022-1759(86)90473-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Specificity studies of an antibody developed against a mucin-type glycoprotein.

Authors:  S Haavik; M Nilsen; T Thingstad; H Barsett; D V Renouf; E F Hounsell; J F Codington
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

2.  Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.

Authors:  C B Tyler; J M Bidlack
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

3.  Production of engineered IgM-binding single-chain antibodies in Escherichia coli.

Authors:  T K Lee; M L Rollence; P L Hallberg; M S Oelkuct; S W Dodd; J W Nagle; D R Filpula
Journal:  J Ind Microbiol       Date:  1995-05

4.  Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody.

Authors:  G N Gaulton; M I Greene
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.